Teladoc Health, Inc. (TDOC) Net Income CAGR:N/A(TTM)
Net income CAGR uses precomputed financial statement history.
Over the past 12 months, Teladoc Health, Inc.'s Net Income CAGR is N/A.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Net income CAGR shows how Teladoc Health, Inc.'s bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.
TDOC Net Income CAGR Chart
TDOC Quarterly Net Income Growth (YoY)
Net Income growth vs the same quarter one year earlier, last 20 quarters.
TDOC Net Income CAGR History
| Year | Start Net Income | End Net Income | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $-1.00B | $-200.32M | +$800.92M | N/A | N/A |
| 2024 | $-220.37M | $-1.00B | $-780.88M | N/A | N/A |
| 2023 | $-13.66B | $-220.37M | +$13.44B | N/A | N/A |
| 2022 | $-428.79M | $-13.66B | $-13.23B | N/A | N/A |
| 2021 | $-485.14M | $-428.79M | +$56.34M | N/A | N/A |
| 2020 | $-98.86M | $-485.14M | $-386.27M | N/A | N/A |
| 2019 | $-97.08M | $-98.86M | $-1.78M | N/A | N/A |
| 2018 | $-106.78M | $-97.08M | +$9.70M | N/A | N/A |
| 2017 | $-74.22M | $-106.78M | $-32.57M | N/A | N/A |
| 2016 | $-58.02M | $-74.22M | $-16.20M | N/A | N/A |
| 2015 | $-17.04M | $-58.02M | $-40.98M | N/A | N/A |
| 2014 | $-6.02M | $-17.04M | $-11.02M | N/A | N/A |
Quarterly Net Income: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | -$63.84M | -153.9% | +31.4% |
| Q4 2025 | -$25.14M | +49.2% | +48.1% |
| Q3 2025 | -$49.51M | -51.6% | -48.8% |
| Q2 2025 | -$32.66M | +64.9% | +96.1% |
| Q1 2025 | -$93.01M | -92.1% | -13.6% |
| Q4 2024 | -$48.41M | -45.5% | -67.6% |
| Q3 2024 | -$33.28M | +96.0% | +41.7% |
| Q2 2024 | -$837.67M | -922.9% | -1185.2% |
| Q1 2024 | -$81.89M | -183.5% | -18.3% |
| Q4 2023 | -$28.89M | +49.4% | +99.2% |
| Q3 2023 | -$57.07M | +12.4% | +22.3% |
| Q2 2023 | -$65.18M | +5.9% | +97.9% |
| Q1 2023 | -$69.23M | +98.2% | +99.0% |
| Q4 2022 | -$3.81B | -5085.5% | -34584.3% |
| Q3 2022 | -$73.48M | +97.6% | +12.9% |
| Q2 2022 | -$3.10B | +53.5% | -2217.7% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita